3542 Federal Register / Vol. 87, No. 15 / Monday, January 24, 2022 / Notices 

Prevention, 100 Totius Street, 

Groenkloof, Pretoria, South Africa, 

Telephone: 800–232–6348, Email: 

edu9@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

single-source award will support the 

SAG in four broad areas of public health 

surveillance and response: 

Communicable (e.g., HIV and TB) and 

non-communicable disease surveillance, 

public health laboratory capacity, public 

health workforce development, and 

global health security. The NICD, under 

the National Public Health Institute of 

South Africa (NAPHISA), is in a unique 

position to conduct this work, through 

an act of parliament mandating the 

organization to provide microbiology, 

virology, epidemiology, surveillance 

and public health research and training 

to support the government’s response to 

communicable disease threats. 

Summary of the Award 

Recipient: National Institute for 

Communicable Diseases (NICD), South 

Africa. 

Purpose of the Award: The purpose of 

this award is to provide accurate, 

timely, and high-quality strategic 

information to enable the SAG to track 

critical infectious disease pathogens, 

monitor interventions, and inform 

policy and programming to reduce 

disease transmission and burden. 

Amount of Award: The approximate 

year 1 funding amount will be 

$5,000,000 in Federal Fiscal Year (FFY) 

2022 funds, subject to the availability of 

funds. Annual award amounts for years 

2–5 will be set at continuation. 

Authority: This program is authorized 

under Public Law 108–25 (the United 

States Leadership Against HIV AIDS, 

Tuberculosis and Malaria Act of 2003). 

Period of Performance: September 30, 

2022, through September 29, 2027. 

Dated: January 19, 2022. 

Terrance Perry, 

Chief Grants Management Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2022–01271 Filed 1–21–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–22–22BY; Docket No. CDC–2022– 

0008] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Importation Regulations (42 CFR 

71 subpart F), which specifies the 

requirements for importing animals or 

animal products that are regulated by 

CDC into the United States. 

DATES: CDC must receive written 

comments on or before March 25, 2022. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2022– 

0008 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Importation Regulations (42 CFR 71 

Subpart F)—New—National Center for 

Emerging and Zoonotic Infectious 

Diseases (NCEZID), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

This is a request for a new 

information collection to consolidate 

forms and information collections 

related to the importation of animals, 

animal products, and human remains 

into one information collection. This 

information collection was previously 

part of three separate, OMB-approved 

information collections: (1) 0920–1034 

(expires 3/31/2022), (2) 0920–0263 

(expires 9/30/2023), and (3) 0920–0199 

(expires 8/31/2024). CDC is requesting a 

three-year OMB clearance for this new, 

combined information collection. 

Section 361 of the Public Health 

Service Act (PHSA) (42 U.S.C. 264) 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 15 / Monday, January 24, 2022 / Notices 3543 

authorizes the Secretary of Health and 

Human Services to make and enforce 

regulations necessary to prevent the 

introduction, transmission or spread of 

communicable diseases from foreign 

countries into the United States. The 

Statute, and the existing regulations 

governing foreign quarantine activities 

(42 CFR 71), authorize quarantine 

officers and other personnel to inspect 

and undertake necessary control 

measures with respect to conveyances, 

persons, and shipments of animals and 

etiologic agents in order to protect the 

public’s health. 

CDC regulations govern the 

importation of animals and animal 

products capable of causing human 

disease. Animals that are regulated by 

CDC are dogs, cats, turtles, snakes, 

lizards, non-human primates (NHP), 

civets, African rodents, and bats. CDC 

controls the importation of these 

animals to ensure that these animals, or 

animal products, being imported into 

the United States meet CDC regulations. 

CDC does this through a permitting 

process for certain animals. 

On June 16, 2021 CDC published a 

Federal Register Notice informing the 

public about a temporary suspension of 

dogs entering the United States from 

high-risk rabies countries. The canine 

rabies virus variant (CRVV) was 

declared eliminated in the United States 

in 2007. The importation of just one dog 

infected with CRVV risks reintroduction of the virus into the United 

States resulting in a potential public 

health risk with consequent monetary 

cost and potential loss of human and 

animal life. Since 2015 there have been 

four known rabid dogs imported into 

the United States. 

During the suspension period, CDC 

will issue permits for importers with 

dogs who have been in a high-risk 

CRVV country within the last six 

months and do not have a current, valid 

U.S.-issued rabies vaccination 

certificate. Only importers who are 

permanently relocating to the United 

States, are a US government employee 

traveling on official orders, are an owner 

of a service dog that is trained to assist 

them with a disability, are an individual 

importing dogs for science, education, 

exhibition, or law enforcement 

purposes, or people who traveled with 

their dog before July 31, 2021 are 

eligible to apply for a permit. Dogs from 

CRVV-free or low risk countries and 

dogs with valid U.S.-issued rabies 

vaccination certificates that are 

microchipped, healthy, and at least six 

months of age do not require a permit. 

The current permit application to 

import a dog is under collection 0920– 

1034. When a dog or cat arrives at an 

airport and is sick or dead, importers are 

required to notify CDC. There is no form 

for this notification. 

Other animals that require a permit, 

and are included in this information 

collection are NHPs, which can carry of 

number of diseases that can cause 

severe infections in people. NHPs may 

not be imported as pets and may only 

be imported for bona fide scientific, 

educational, or exhibition purposes, as 

defined in the regulations. Forms for the 

importation of NHPs are currently under 

information collection 0920–0263. 

These forms will move into this new 

information collection to consolidate all 

forms related to the importation of 

animals or animal products into one 

collection. 

A new form to request a permit to 

import a regulated animal that is neither 

a dog nor an NHP (e.g., turtles, African 

rodents, civets) is included in this 

information collection. It also 

incorporates the addition of bats, which 

is currently approved under OMB 

control number 0920–0199. 

Regarding human remains, the 

Division of Global Migration and 

Quarantine (DGMQ) works with the 

Division of Select Agents and Toxins 

(DSAT) on the importation for human 

remains. DGMQ requests death 

certificates from those wishing to import 

remains and then determines if the 

importer will need a permit, which is 

issued by DSAT and will remain in 

0920–0199. 

Lastly, people importing animal 

products must make a statement or 

provide documentation demonstrating 

that the animal product is not 

infectious. 

CDC requests approval for an 

estimated 60,215 annual burden hours. 

There are no costs to respondents other 

than their time to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Dog Importers (42 CFR 71.51(c)(2), 

(d)).

Dog Permit Application Form ........... 60,000 1 60/60 60,000 

NHP Importers (42 CFR 71.53) ........ NHP Shipment Arrival Notification 

Form.

120 1 15/60 30 

First Time NHP Importer (42 CFR 

71.53).

NHP Importer Form .......................... 15 1 120/60 30 

Regulated Animal Importer (42 CFR 

71).

Other animal import form ................. 2 1 30/60 1 

Dog and Cat Importers (42 CFR 

71.51(b)(3)).

Record of sickness or death ............ 43 1 60/60 43 

Human Remains Importers (42 CFR 

71.55, 42 CFR 71.32).

Provide death certificate .................. 50 1 15/60 13 

Importer of animal products (42 CFR 

71.32).

Statement or documentation of noninfectiousness.391 1 15/60 98 

Total ........................................... ........................................................... ........................ ........................ ........................ 60,215 


jspears on DSK121TN23PROD with NOTICES1
3544 Federal Register / Vol. 87, No. 15 / Monday, January 24, 2022 / Notices 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–01260 Filed 1–21–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Award of a Single-Source 

Cooperative Agreement To Fund the 

Republican AIDS Center, Kyrgyz 

Republic 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS), announces the 

award of approximately $2,000,000 for 

Year 1 of funding to the Republican 

AIDS Center, Kyrgyz Republic (KR). The 

award will build on previous 

President’s Emergency Plan for AIDS 

Relief (PEPFAR) program support to 

ensure continuity of high-quality HIV 

services to existing clients across the 

HIV cascade, the steps of care (from 

diagnosis to achieving viral load (VL) 

suppression) for people living with HIV 

(PLHIV), and achieve the Joint United 

Nations Programme on HIV/AIDs 

(UNAIDS) 95–95–95 goals (95% of HIVpositive individuals knowing their 

status, 95% of those receiving ART 

[Antiretroviral therapy], and 95% of 

those achieving viral suppression). 

Annual award amounts for years 2–5 

will be set at continuation. 

DATES: The period for this award will be 

September 30, 2022, through September 

29, 2027. 

FOR FURTHER INFORMATION CONTACT: 

Patrick Nadol, Center for Global Health, 

Centers for Disease Control and 

Prevention, U.S. Embassy Bishkek, 171 

Prospect Mira, Bishkek 720016 Kyrgyz 

Republic, Telephone: 800–232–6348, 

Email: pen5@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

single-source award will allow for 

implementation of high-quality care and 

treatment programs with a focus on 

same-day antiretroviral therapy (SD– 

ART) initiation. Programs will utilize 

innovative approaches to ART 

adherence and participant retention; as 

well as HIV testing and counseling 

(HTC), and prevention programs that 

focus on pre-exposure prophylaxis 

(PrEP) and opioid substitution therapy 

(OST). The key focus of the project will 

be integration of the Republican AIDS 

Center’s granular site management 

project in PEPFAR-supported subnational units to the national scale to 

improve quality of provided services to 

PLHIV and institutionalize quality 

management system and incorporate 

into national HIV plan. 

The Republican AIDS Center (RAC) is 

in a unique position to conduct this 

work in the Kyrgyz Republic, as it is the 

leading organization responsible for 

National HIV Program implementation 

under the Ministry of Health and Social 

Development. In the Kyrgyz Republic, 

the Ministry of Health and Social 

Development has mandated the RAC to 

lead and coordinate the national 

response to HIV/AIDS, including 

developing and regulating national HIV 

guidelines and policies. 

Summary of the Award 

Recipient: Republican AIDS Center, 

Kyrgyz Republic. 

Purpose of the Award: The purpose of 

this award is to build on previous 

PEPFAR program support to ensure 

continuity of high-quality HIV services 

to existing clients across the HIV 

cascade and achieve the UNAIDS 95– 

95–95 goals. The award will support a 

comprehensive and integrated HIV 

program (e.g.: Surveillance, prevention, 

and treatment to prevent new 

infections), improve health outcomes for 

PLHIV (i.e.: Achieving and sustaining 

VL suppression), reduce HIV 

transmission and mortality in 

accordance with KR’s national 

prevention goal, and strengthen public 

health functions to address other health 

priorities. 

Amount of Award: The approximate 

year 1 funding amount will be 

$2,000,000 in Federal Fiscal Year (FFY) 

2022 funds, subject to the availability of 

funds. Annual award amounts for years 

2–5 will be set at continuation. 

Authority: This program is authorized 

under Public Law 108–25 (the United 

States Leadership Against HIV AIDS, 

Tuberculosis and Malaria Act of 2003). 

Period of Performance: September 30, 

2022, through September 29, 2027. 

Dated: January 19, 2022. 

Terrance Perry, 

Chief Grants Management Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2022–01266 Filed 1–21–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Award of a Single-Source 

Cooperative Agreement To Fund the 

Vietnam Department of Animal Health 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS), announces the 

award of approximately $1,000,000, 

with an expected total funding of 

approximately $5,000,000 over a fiveyear project period, to the Vietnam 

Department of Animal Health. The 

award will strengthen capabilities and 

maintain the government run 

laboratory-supported surveillance at the 

animal-human interface for avian and 

non-avian influenza viruses, other 

zoonotic diseases (e.g., rabies, African 

Swine Fever, etc.), and other respiratory 

zoonotic viruses (e.g., SARS–CoV–2) in 

Vietnam. 

DATES: The period for this award will be 

September 30, 2022, through September 

29, 2027. 

FOR FURTHER INFORMATION CONTACT: Nga 

Vuong, National Center for 

Immunization and Respiratory Diseases, 

Centers for Disease Control and 

Prevention, 1600 Clifton Rd. NE, MS 

H24–7, Atlanta, GA 30329, Telephone: 

800–232–6348. 

SUPPLEMENTARY INFORMATION: The 

single-source award will strengthen 

capabilities and maintain the 

government run laboratory-supported 

surveillance at the animal-human 

interface for avian and non-avian 

zoonotic influenza viruses, other 

zoonotic diseases, and other respiratory 

zoonotic viruses in Vietnam. 

The Vietnam Department of Animal 

Health (DAH) is in a unique position to 

conduct this work because of their 

position as the sole official, authorized 

governmental agency with the legal and 

regulatory authority and ability to lead 

and manage animal health and pathogen 

surveillance. DAH provides technical 

management and oversight to its subdepartments across the country to 

implement animal surveillance and 

related activities such as outbreak 

investigation. DAH’s 7 Regional Animal 

Health Offices (RAHOs) are strategically 

located throughout the country and 

have in-house lab testing capacity. DAH 

is at the center of a national network of 


jspears on DSK121TN23PROD with NOTICES1